Med-Chemist : "Quintessential Medicinal Chemistry"
Thursday, August 18, 2016
Soy shows promise as natural anti-microbial agent
›
In continuation of my update on soy Soy isoflavones and peptides may inhibit the growth of microbial pathogens that cause food-borne i...
Wednesday, August 17, 2016
New drug combination before surgery may improve outcomes in breast cancer patients
›
In continuation of my update on Paclitaxel Results from the I-SPY 2 trial show that giving patients with HER2-positive invasi...
Tuesday, August 16, 2016
New clinical study to evaluate inexpensive drug to prevent type 1 diabetes
›
I n continuation of my update on metformin New trial aims to prevent type 1 diabetes A clinical study evaluating a new hyp...
Monday, August 15, 2016
Experimental treatment shrinks rare pediatric tumor by 90%
›
In continuation of my update on LOXO-101 When a baby's life was threatened by a rare pediatric cancer that would not respond ...
Friday, August 12, 2016
Scientists develop new drug for life-threatening lung disease treatment
›
Researchers are developing a new drug to treat life-threatening lung damage and breathing problems in people with severe infections like p...
1 comment:
Thursday, August 11, 2016
Frontline nilotinib supported for newly diagnosed CP-CML
›
Long-term results from the ENESTnd trial indicate a favourable risk-benefit profile for frontline use of nilotinib in patients wit...
Wednesday, August 10, 2016
Antidepressant Wellbutrin linked to long-term modest weight loss
›
Group Health researchers have found that bupropion (marketed as Wellbutrin) is the only antidepressant that tends to be linked to long-te...
Tuesday, August 9, 2016
Novel combination of cancer drugs can have therapeutic impact on diffuse large B-cell lymphoma
›
In continuation of my update on carfilzomib , JQ1 and ABT 199 New research from Roswell Park Cancer Institute (RPCI) shows that...
Monday, August 8, 2016
Potential first-in-class treatment is well-tolerated in patients with chronic hepatitis B: Phase 1 study shows the investigational capsid assembly inhibitor NVR 3-778 combined with pegylated interferon reduces levels of hepatitis B more than NVR 3-778 alone.
›
New data presented today confirms that a novel first-in-class treatment for Hepatitis B, called NVR 3-778, is well-tolerated and can reduc...
Friday, August 5, 2016
Once-a-day epilepsy drug may prevent seizures as well as twice-a-day drug
›
In continuation of my update on Carbamazepine ( CBZ ) A new study suggests that an epilepsy drug that can be taken once a day may co...
Thursday, August 4, 2016
LOXO-101 drug shows efficacy with tumor regression in varied types of genetically defined cancer
›
A phase I study of the drug LOXO-101 appears to significantly reduce tumors in patients with varied types of genetically defined can...
New triple drug combination shows promise in hepatitis C infected patients: High sustained virologic response achieved with sofosbuvir/velpatasvir and GS-9857, even in patients unsuccessfuly treated with direct-acting antivirals
›
New data presented today at The International Liver Congress™ 2016 in Barcelona, Spain, demonstrates a high sustained virologic response (...
Wednesday, August 3, 2016
Experimental drug guadecitabine found safe in patients with colorectal cancer: Combination with standard chemotherapy shows promise in overcoming treatment resistance
›
In continuation of my update on guadecitabine (SGI-110) In a small, phase I clinical trial, Johns Hopkins Kimmel Cancer Center re...
Tuesday, August 2, 2016
Study demonstrates therapeutic potential of SOD-mimetic compound M40403 against Parkinson disease
›
Parkinson disease is a debilitating and incurable neurodegenerative disorder, affecting approximately 1-2% of people over sixty-five years...
Monday, August 1, 2016
Cyclodextrin dissolves cholesterol crystals, reduces atherosclerotic plaques
›
In continuation of my update of cyclodextrin Cardiovascular disease from atherosclerosis is one of the most common causes of de...
‹
›
Home
View web version